Gilead Sciences Inc
NASDAQ: GILD
$111.03
+$1.08 (+1.0%)
Closing Price on February 24, 2025
GILD Articles
Wednesday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Chipotle Mexican Grill, Ford, Goldman Sachs, Grubhub, New Relic, Pinterest, Snap, Tesla and Walt Disney.
Published:
Gilead Sciences shares jumped on Monday after the company announced that it is currently working with China to develop an effective treatment for the coronavirus.
Published:
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.
Published:
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
Published:
These five top picks from the RBC all make sense for growth investors looking to move to companies with more reasonable valuations.
Published:
Last Updated:
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap and Wayfair.
Published:
Last Updated:
The November 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data has been compared with the previous report, and short interest in...
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in...
Published:
Last Updated:
These four health care stocks look like solid picks for the fourth quarter and into 2020. They are also favorite picks from Raymond James analysts.
Published:
The October 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Published:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.